Does ductal carcinoma in situ accompanying invasive carcinoma affect prognosis?

Surgery

Volumn 146, Issue 4, 2009, Pages 561-568

  Chagpar, Anees B ^a   McMasters, Kelly M ^a   Sahoo, Sunati ^a   Edwards, Michael J ^b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; TOREMIFENE;

ADJUVANT THERAPY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; DISTANT METASTASIS; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; KAPLAN MEIER METHOD; LOCAL METASTASIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOME ASSESSMENT; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PROGNOSIS;

EID: 70349317022     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2009.06.039     Document Type: Article

References (19)

1. American Cancer Society. Breast Cancer Facts & Figures 2007-2008 (2007), American Cancer Society, Inc, Atlanta
2. Hofvind S., Sorum R., and Thoresen S. Incidence and tumor characteristics of breast cancer diagnosed before and after implementation of a population-based screening-program. Acta Oncol 47 (2008) 225-231
3. Kuerer H.M., Albarracin C.T., Yang W.T., et al. Ductal carcinoma in situ: state of the science and roadmap to advance the field. J Clin Oncol 27 (2009) 279-288
4. Erbas B., Provenzano E., Armes J., et al. The natural history of ductal carcinoma in situ of the breast: a review. Breast Cancer Res Treat 97 (2006) 135-144
5. Black M.M., Zachrau R.E., Hankey B.F., et al. Prognostic significance of in situ carcinoma associated with invasive breast carcinoma. A natural experiment in cancer immunology?. Cancer 78 (1996) 778-788
6. Iakovlev V.V., Arneson N.C., Wong V., et al. Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease: a calibrated aCGH study. Clin Cancer Res 14 (2008) 4446-4454
7. Castro N.P., Osorio C.A., Torres C., et al. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma. Breast Cancer Res 10 (2008) R87
8. Singletary S.E., Allred C., Ashley P., et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20 (2002) 3628-3636
9. Dillon M.F., Maguire A.A., McDermott E.W., et al. Needle core biopsy characteristics identify patients at risk of compromised margins in breast conservation surgery. Mod Pathol 21 (2008) 39-45
10. Mai K.T., Perkins D.G., and Mirsky D. Location and extent of positive resection margins and ductal carcinoma in situ in lumpectomy specimens of ductal breast carcinoma examined with a microscopic three-dimensional view. Breast J 9 (2003) 33-38
11. Dzierzanowski M., Melville K.A., Barnes P.J., et al. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins. J Surg Oncol 90 (2005) 71-76
12. Jimenez R.E., Bongers S., Bouwman D., et al. Clinicopathologic significance of ductal carcinoma in situ in breast core needle biopsies with invasive cancer. Am J Surg Pathol 24 (2000) 123-128
13. Kurniawan E.D., Wong M.H., Windle I., et al. Predictors of surgical margin status in breast-conserving surgery within a breast screening program. Ann Surg Oncol 15 (2008) 2542-2549
14. Logullo A.F., Godoy A.B., Mourao-Neto M., et al. Presence of ductal carcinoma in situ confers an improved prognosis for patients with T1N0M0 invasive breast carcinoma. Braz J Med Biol Res 35 (2002) 913-919
15. Matsukuma A., Enjoji M., and Toyoshima S. Ductal carcinoma of the breast. An analysis of proportions of intraductal and invasive components. Pathol Res Pract 187 (1991) 62-67
16. Leong A.S., Sormunen R.T., Vinyuvat S., et al. Biologic markers in ductal carcinoma in situ and concurrent infiltrating carcinoma. A comparison of eight contemporary grading systems. Am J Clin Pathol 115 (2001) 709-718
17. Gupta S.K., Douglas-Jones A.G., Fenn N., et al. The clinical behavior of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ). Cancer 80 (1997) 1740-1745
18. Moriya T., and Silverberg S.G. Intraductal carcinoma (ductal carcinoma in situ) of the breast. A comparison of pure noninvasive tumors with those including different proportions of infiltrating carcinoma. Cancer 74 (1994) 2972-2978
19. Mechera R., Viehl C.T., and Oertli D. Factors predicting in-breast tumor recurrence after breast-conserving surgery. Breast Cancer Res Treat 116 (2008) 171-177